logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Popular
  • Life Science & Technology Weekly 159 – RootPath Receives $7 Million Seed Funding for Next-Gen Immuno-Oncology

Life Science & Technology Weekly 159 – RootPath Receives $7 Million Seed Funding for Next-Gen Immuno-Oncology

NAI Life Science & Technology - www.nai500.com
Published on: Sep 6, 2018
Author: Editor
  • Share article:

Check www.nai500.com for more investment opportunities

 

Suggested Opportunity

Tenet Fintech Group Inc.

Tenet Fintech Group Inc. (CSE: PKK, OTC Pink: PKKFF)

Commercial Lending in China Ready to Tenet!

Click here to find more details

This is NAI’s new Life Science and Technology Weekly. We will be covering the latest news in life science, pharmaceutical, biotech and technology sectors every week. To continue to receive NAI’s Life Science and Technology Weekly, please click Here to subscribe.

Biotechnology Blockchain Life Science Technology

Related Posts

强生公司股票当前是否值得买入?

Johnson & Johnson Maintains Steady Dividends While Eli Lilly Bets on the Weight-Loss Drug Track

LME Lead Stocks Surge 58% in Two Days as India-China Trade Flows Reshape the Market

Accenture Stock Soars After Earnings Beat Expectations, AI Disruption Fears Temporarily Eased

英伟达10亿美元投资诺基亚,强劲涨势能否延续?

Nokia Partners with ICEYE to Build Europe’s Sovereign Satellite Communications Network

从7000%到43%:比特币减半效应为何逐渐减弱?

Bank of England Warns of Sovereign Debt and AI Lending Risks, Bitcoin’s Monetary Attributes Draw Renewed Attention

美国股市大幅下挫,IPO企业定价须合理才能吸引投资者

Anthropic Seeks to Launch IPO in November, With Valuation Expected to Reach as High as $2 Trillion

AbbVie vs. Bristol Myers Squibb: A Clash Between Growth Premium and Value Trap

AbbVie vs. Bristol Myers Squibb: A Clash Between Growth Premium and Value Trap

Related News

Johnson & Johnson Maintains Steady Dividends While Eli Lilly Bets on the Weight-Loss Drug Track

14 hours ago.

Accenture Stock Soars After Earnings Beat Expectations, AI Disruption Fears Temporarily Eased

15 hours ago.

Nokia Partners with ICEYE to Build Europe’s Sovereign Satellite Communications Network

15 hours ago.

Bank of England Warns of Sovereign Debt and AI Lending Risks, Bitcoin’s Monetary Attributes Draw Renewed Attention

17 hours ago.

Top Stories

Down 22%, Still 327x: Tesla's Slump Failed to Dent Its Valuation
Technology

Down 22%, Still 327x: Tesla’s Slump Failed to Dent Its Valuation

NFT市场遇冷,耐克悄然出售数字子公司RTFKT
Consumer Goods

Nike’s First Quarter Revenue Reaches $11.2 Billion as Pace Transformation Plan Officially Takes Effect

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada